162 related articles for article (PubMed ID: 15123284)
61. Diastereomers of dibromo-7-epi-10-deacetylcephalomannine: crowded and cytotoxic taxanes exhibit halogen bonds.
Jiang Y; Alcaraz AA; Chen JM; Kobayashi H; Lu YJ; Snyder JP
J Med Chem; 2006 Mar; 49(6):1891-9. PubMed ID: 16539375
[TBL] [Abstract][Full Text] [Related]
62. Quantum-chemical study on the bioactive conformation of epothilones.
Jiménez VA
J Chem Inf Model; 2010 Dec; 50(12):2176-90. PubMed ID: 21077585
[TBL] [Abstract][Full Text] [Related]
63. Total synthesis and evaluation of C25-benzyloxyepothilone C for tubulin assembly and cytotoxicity against MCF-7 breast cancer cells.
Hutt OE; Reddy BS; Nair SK; Reiff EA; Henri JT; Greiner JF; Chiu TL; Vandervelde DG; Amin EA; Himes RH; Georg GI
Bioorg Med Chem Lett; 2008 Sep; 18(17):4904-6. PubMed ID: 18684624
[TBL] [Abstract][Full Text] [Related]
64. Activity of epothilones.
Kolman A
Curr Opin Investig Drugs; 2005 Jun; 6(6):616-22. PubMed ID: 15988913
[TBL] [Abstract][Full Text] [Related]
65. Mechanism of action of tubulysin, an antimitotic peptide from myxobacteria.
Khalil MW; Sasse F; Lünsdorf H; Elnakady YA; Reichenbach H
Chembiochem; 2006 Apr; 7(4):678-83. PubMed ID: 16491500
[TBL] [Abstract][Full Text] [Related]
66. Mapping the bound conformation and protein interactions of microtubule destabilizing peptides by STD-NMR spectroscopy.
Milton MJ; Thomas Williamson R; Koehn FE
Bioorg Med Chem Lett; 2006 Aug; 16(16):4279-82. PubMed ID: 16765596
[TBL] [Abstract][Full Text] [Related]
67. Crystal structures of epothilone D-bound, epothilone B-bound, and substrate-free forms of cytochrome P450epoK.
Nagano S; Li H; Shimizu H; Nishida C; Ogura H; Ortiz de Montellano PR; Poulos TL
J Biol Chem; 2003 Nov; 278(45):44886-93. PubMed ID: 12933799
[TBL] [Abstract][Full Text] [Related]
68. Mechanical and functional properties of epothilone-stabilized microtubules.
Yu D; Pessino V; Kuei S; Valentine MT
Cytoskeleton (Hoboken); 2013 Feb; 70(2):74-84. PubMed ID: 23135951
[TBL] [Abstract][Full Text] [Related]
69. Oxoisoaporphine alkaloid derivatives: synthesis, DNA binding affinity and cytotoxicity.
Tang H; Wang XD; Wei YB; Huang SL; Huang ZS; Tan JH; An LK; Wu JY; Chan AS; Gu LQ
Eur J Med Chem; 2008 May; 43(5):973-80. PubMed ID: 17720282
[TBL] [Abstract][Full Text] [Related]
70. 3D QSAR studies of the interaction between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA). A combined pharmacophore generation and pseudoreceptor modeling approach applied to taxanes and epothilones.
Manetti F; Forli S; Maccari L; Corelli F; Botta M
Farmaco; 2003 May; 58(5):357-61. PubMed ID: 12729829
[TBL] [Abstract][Full Text] [Related]
71. An interesting observation of the position of some electronegative atoms in the taxol molecule.
Cheng CC; Gordon MA
Med Hypotheses; 2000 Feb; 54(2):172-6. PubMed ID: 10790745
[TBL] [Abstract][Full Text] [Related]
72. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
73. -NH-dansyl isocolchicine exhibits a significantly improved tubulin-binding affinity and microtubule inhibition in comparison to isocolchicine by binding tubulin through its A and B rings.
Das L; Datta AB; Gupta S; Poddar A; Sengupta S; Janik ME; Bhattacharyya B
Biochemistry; 2005 Mar; 44(9):3249-58. PubMed ID: 15736935
[TBL] [Abstract][Full Text] [Related]
74. Targeting the microtubules in breast cancer beyond taxanes: the epothilones.
Cortes J; Baselga J
Oncologist; 2007 Mar; 12(3):271-80. PubMed ID: 17405891
[TBL] [Abstract][Full Text] [Related]
75. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
Paula S; Monson N; Ball WJ
Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
[TBL] [Abstract][Full Text] [Related]
76. Understanding the basis of drug resistance of the mutants of αβ-tubulin dimer via molecular dynamics simulations.
Natarajan K; Senapati S
PLoS One; 2012; 7(8):e42351. PubMed ID: 22879949
[TBL] [Abstract][Full Text] [Related]
77. [Efficacy and safety of ixabepilone (BMS-247550), a novel epothilone B analogue].
Villanueva C; Dufresne A; Pivot X; Viel E
Bull Cancer; 2008 Feb; 95(2):197-204. PubMed ID: 18304905
[TBL] [Abstract][Full Text] [Related]
78. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
[TBL] [Abstract][Full Text] [Related]
79. Characterization of the hollow fiber assay for the determination of microtubule disruption in vivo.
Suggitt M; Swaine DJ; Pettit GR; Bibby MC
Clin Cancer Res; 2004 Oct; 10(19):6677-85. PubMed ID: 15475458
[TBL] [Abstract][Full Text] [Related]
80. C6-C8 bridged epothilones: consequences of installing a conformational lock at the edge of the macrocycle.
Zhan W; Jiang Y; Sharma S; Brodie PJ; Bane S; Kingston DG; Liotta DC; Snyder JP
Chemistry; 2011 Dec; 17(52):14792-804. PubMed ID: 22127984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
